Recent Articles from Investor Brand Network

Versus Systems (NASDAQ: VS) announced the renewal of its partnership with the Texas Rangers for continued use of its Filter Fan Cam platform at Globe Life Field through the 2026 Major League Baseball season. The agreement extends a five-year collaboration and introduces upgraded technology designed to enhance in-stadium fan engagement, including improved real-time facial tracking, lower latency through a 60-frames-per-second camera driver and new dynamic face paint filter capabilities that create interactive branded experiences for fans while expanding sponsorship and revenue opportunities for the company.

AI Maverick Intel (OTC: AIMV) announced it has entered into a Right of First Refusal Agreement with HEAL Group Holdings Inc., giving the company the ability to review and match third-party offers for certain HEAL assets or business units under specified conditions. The agreement, effective Feb. 11, 2026, provides AIMV with potential acquisition access across HEAL’s portfolio of AI-driven healthcare technology and services operating in more than six countries, in exchange for issuing 120,000,000 common shares to HEAL at a deemed price of $0.02 per share, representing total consideration of $2.4 million, with the arrangement remaining in place for three years unless terminated earlier by mutual agreement.

TYTL, a residential real estate tokenization platform, announced the closing of a seed funding round led by Strobe Ventures with participation from Fifth Era, alongside strategic partnerships with Beeline Holdings (NASDAQ: BLNE) and Anchorage Digital Bank. The company said its platform provides a debt-free alternative for homeowners to access equity by selling fractional ownership interests in qualifying residential properties rather than taking on loans such as HELOCs or reverse mortgages, with interests recorded through traditional deed processes and subsequently published on-chain using Solana-based infrastructure.

TYTL, a residential real estate tokenization platform, announced the closing of a seed funding round led by Strobe Ventures with participation from Fifth Era, alongside strategic partnerships with Beeline Holdings (NASDAQ: BLNE) and Anchorage Digital Bank. The company said its platform provides a debt-free alternative for homeowners to access equity by selling fractional ownership interests in qualifying residential properties rather than taking on loans such as HELOCs or reverse mortgages, with interests recorded through traditional deed processes and subsequently published on-chain using Solana-based infrastructure.

Investigative newspaper examines compliance oversight and market manipulation claims tied to CIBC leadership and a $700M lawsuit

A new study from Anthropic, the AI firm behind the chatbot Claude, offers an early look at how AI could reshape the American workforce .

As 2025 came to a close, the Finance Minister of the Democratic Republic of Congo announced that the country had recommenced its exports of cobalt. This comes after a 10-month hiatus that was introduced early last year.

Renewal Fuels (OTC: RNWF) issued a statement denying a report circulating on online message boards and social media that falsely claims the company has announced a public offering of common stock. The company confirmed that it has not authorized, filed for or engaged any investment bank to conduct such an offering, and that the document circulating online — which mimics the format of a GlobeNewswire release — is fabricated and was not distributed by GlobeNewswire or any authorized news service used by the company. Management said it is reviewing the source of the false report and urged investors to rely only on official company announcements distributed through verified communication channels.

Voyager Acquisition (NASDAQ: “VACHU,” “VACH,” “VACHW”) announced that holders of 25,217,315 Class A ordinary shares — representing approximately 99.67% of the shares outstanding — exercised their redemption rights in connection with the company’s planned business combination with VERAXA Biotech AG. Following the redemptions, approximately $885,556 will remain in Voyager’s trust account and 82,685 Class A shares will convert into shares of VERAXA Biotech Holding AG, with the combined company expected to trade on Nasdaq under the ticker “VRXA” upon completion of the transaction.

Artificial intelligence is often described as a tool that will make work easier and faster. Many companies are introducing AI systems to help employees complete tasks, analyze information, and improve productivity. However, a recent study suggests that using too many AI tools at work may actually create a new kind of mental exhaustion for employees.

New research has uncovered a shared biological weakness running across three distinct pediatric brain cancers, a finding that opens a realistic path toward therapies capable of targeting all three at once. The discovery grew out of a deep dive into one of the rarest childhood tumors on record and ended up revealing far more than anyone initially set out to find.

For years, most established companies kept their distance from crypto payments. That stance is gradually shifting . As businesses reassess how they handle transactions, many are focusing on factors such as cost efficiency, convenience, security, and speed.

Stocks of U.S. banks struggled in February 2026, performing worse than the broader stock market. New data from market analysts shows that the banking sector faced a difficult month as investors reacted to economic uncertainty, company deals, and changing expectations in the financial industry.

Platinum experienced volatile trading as the week started and closed on Monday near the $2,150 price mark. The recent rebound of the precious metal is supporting its price, though further gains are being tempered by a spike in oil prices, a rebounding dollar and stronger yields on U.S. Treasuries.

This article has been disseminated on behalf of LaFleur Minerals Inc. and may include a paid advertisement.

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising.

Oragenics (NYSE American: OGEN) announced it is exploring potential acquisitions of additional central nervous system assets focused on brain health and brain recovery indications that align with its proprietary intranasal drug delivery platform and lead candidate ONP-002. The company said the initiative complements its existing AI-enabled drug discovery collaboration with Receptor.AI and is intended to build a diversified CNS pipeline, while ONP-002 continues advancing through Phase IIa clinical trials in Australia targeting concussion and mild traumatic brain injury with plans for U.S. Phase IIb studies following a future IND submission.

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

NanoViricides, Inc. (NYSE American: NNVC) announced that it will present at NIBA’s 152nd Investment Conference in Fort Lauderdale on March 12, where President and Executive Chairman Anil R. Diwan will outline progress on the company’s broad-spectrum antiviral platform. The company also reported that manufacturing of its NV-387 Oral Gummies drug product has been completed in preparation for patient dosing once clinical sites are ready, as the therapy advances toward a Phase II trial for monkeypox in the Democratic Republic of Congo following a successful Phase I safety study in healthy volunteers.

NextPlat (NASDAQ: NXPL, NXPLW) announced that its Global Telesat Communications Ltd. subsidiary has been awarded a contract valued at up to approximately $820,000 from a U.K.-based government prime supplier to provide satellite-enabled Internet of Things hardware supporting a NATO military customer. Under the two-year agreement, the company will supply satellite-enabled IoT terminals designed to deliver secure voice, data and asset management connectivity worldwide, leveraging Iridium’s Certus(R) satellite network and dual-mode satellite and LTE capabilities to ensure reliable communications even where terrestrial networks are unavailable.

CNS Pharmaceuticals (NASDAQ: CNSP) announced a new corporate growth strategy aimed at building a high-value pipeline in neurology and oncology through the acquisition or in-licensing of preclinical and clinical-stage therapeutic assets. Following a comprehensive strategic review incorporating clinical probability-of-success modeling, regulatory pathway analysis and market assessments, the company said it will prioritize programs with differentiated mechanisms, clear development pathways and strong commercial potential, while preparing legacy assets TPI 287 and berubicin for potential out-licensing to focus resources on advancing a new acquisition-driven pipeline.

Renewal Fuels (OTC: RNWF) announced the appointment of Sebastian E. Hoyos as chief revenue officer, where he will lead the company’s commercial strategy as it advances development of its Texatron(TM) fusion energy platform. Hoyos brings more than 15 years of experience structuring complex energy transactions and long-term contracted power agreements across U.S. and international electricity markets, including negotiating more than 200 solar and storage contracts and managing large renewable energy portfolios for organizations such as Walmart, ENGIE Impact and Duke Energy. The company said his expertise in power purchase agreements and corporate energy procurement will support efforts to build revenue-generating partnerships and commercial pathways as American Fusion moves toward deployment of its fusion technology.

Datavault AI (NASDAQ: DVLT) announced that CEO Nathaniel “Nate” Bradley will deliver a featured presentation at Luminary 2026 — Film, AI, Music and Crypto Innovators on March 14 at the Beverly Center in Los Angeles as part of Oscars Weekend programming. Bradley will introduce the company’s Tokenized Legacy(TM) platform, a blockchain-based infrastructure designed to enable athletes, musicians and entertainers to permanently manage and monetize name, image and likeness rights through transparent on-chain licensing and automated royalty payments, while the event will also feature demonstrations of Datavault’s ADIO(R) audio data transmission technology and highlight the company’s broader expansion across sports, entertainment and digital asset ecosystems.

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising.

Olenox Industries (NASDAQ: OLOX), a vertically integrated energy company, has appointed Paula J. Dobriansky, a former Under Secretary of State and senior national security official, to its Board of Directors, as the company continues to develop its position as an integrated U.S. energy and infrastructure platform ( https://ibn.fm/WNdzf ).

Pelican Acquisition (NASDAQ: PELI) announced that the leadership team behind the formation of Greenland Energy Company has entered into a strategic logistics agreement with Canadian maritime group Desgagnés to support cargo transportation for planned drilling operations in Greenland’s Jameson Land Basin. The agreement, coordinated with and approved by Royal Arctic Line, provides specialized ice-class vessels and Arctic beach-landing capabilities required to mobilize equipment and crews for the upcoming exploration campaign. The arrangement was executed by March GL Company, which along with Greenland Exploration Ltd. is set to merge with Pelican; upon completion of the business combination, the combined entity is expected to operate as Greenland Energy Company and list on Nasdaq under the ticker symbol “GLND.”

A proposal aimed at restricting the THC amount in individual cannabis edibles will not move forward in Oregon this year after failing to clear the state House of Representatives.

Pelican Acquisition (NASDAQ: PELI) is moving forward with a merger that will create Greenland Energy Company, which plans to drill the first modern exploration wells in Greenland’s remote Jameson Land basin — a frontier petroleum system that some geologists believe could contain more than 13 billion barrels of recoverable oil. According to a report by OilPrice.com’s Tom Kool, the project brings together Texas-based explorer March GL, Greenland Exploration Ltd. and Pelican Acquisition Corp., with veteran oil executive Robert Price expected to lead the combined company once the transaction closes March 17 and the entity begins trading under the ticker GLND.

Nightfood Holdings (d.b.a. TechForce Robotics) (OTCQB: NGTF) is entering a defining chapter in its corporate evolution. The company continues to make expanded inroads into the hospitality and service automation sector, combining AI, robotics, and flexible business models to meet the increased demand for efficiency. According to its recently filed Form 10-Q for the period ended Dec 31, 2025, NGTF reported revenue of $2.97 million and $129.6 million worth of assets, primarily driven by its Robotics-as-a-Service (“RaaS”) platform and hospitality operations ( ibn.fm/zlqzF ). The impressive reports highlight the company’s commitment to integrating intelligent automation into real-world service environments and position the company as a leader in next-generation hospitality solutions.

Disseminated on behalf of MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) and may include paid advertising.

AST SpaceMobile (NASDAQ: ASTS) announced the pricing of $1.0 billion aggregate principal amount of 2.250% convertible senior notes due 2036 in a private offering to qualified institutional buyers under Rule 144A of the Securities Act of 1933. The notes carry an initial conversion price of approximately $116.30 per share, representing a roughly 20% premium to the company’s Feb. 11, 2026 closing price, and the offering is expected to close Feb. 17, 2026, subject to customary conditions. AST SpaceMobile also granted initial purchasers an option to buy up to an additional $150 million of notes, with proceeds expected to support global spectrum deployment, technology commercialization including artificial intelligence opportunities, government space initiatives, debt reduction and other general corporate purposes.

Gaxos.ai (NASDAQ: GXAI) announced that Malcolm B. Frost, a retired Major General in the United States Army, has joined the Drone and Robotics Advisory Council of America First Defense (“AFD”). Frost brings decades of leadership experience in modern warfare, military communications, and advanced defense technologies and will advise AFD on the development of AI-driven autonomous systems, drone defense technologies, and next-generation robotic platforms. The advisory council is composed of military leaders, technologists, and national security experts who guide the company’s efforts to develop solutions addressing the rapidly expanding global market for counter-drone and autonomous defense systems.

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising.

Oragenics (NYSE American: OGEN) announced it has received final Human Research Ethics Committee approval in Australia to begin its Phase IIa clinical trial evaluating ONP-002, its lead intranasal neurosteroid drug candidate for the treatment of concussion, also known as mild traumatic brain injury. With all regulatory approvals secured, the company has initiated clinical site onboarding at three locations in Australia, led by Bayside Health (Alfred Health), and expects to dose the first patient before the end of March. The randomized, placebo-controlled study will enroll 40 patients to evaluate safety, tolerability and feasibility of ONP-002, with data expected before year-end 2026 as the company prepares for a future investigational new drug application to support additional U.S. clinical trials.

Toyota has announced a major update to its electric vehicle lineup, and the centerpiece achieves something the brand has never managed before. The 2027 Highlander EV debuts as the automaker’s first three-row electric SUV. It also becomes the first battery electric Toyota to be assembled on American soil, two milestones wrapped in a single launch.

South Korean scientists have published the results of a study that provides vital insights indicating that brain cancer develops much earlier than the time when tumors become visible. Their findings could alter how brain cancer treatment is approached, especially efforts geared at limiting the possibility of its recurrence.

Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform redefining the path to homeownership, announced that it will host a stakeholder update call on March 30, 2026, to review its fourth-quarter 2025 financial results and outline upcoming initiatives, as the digital mortgage platform looks to build on a year of rapid growth. The call will be led by Chief Executive Officer Nick Liuzza and Chief Financial Officer Chris Moe and is scheduled for 5 p.m. ET. ( https://ibn.fm/0KGwI ).

The strongest argument for transitioning to renewable energy may no longer be combating climate change. Across conflict zones and volatile energy markets, a more urgent case for ditching fossil fuels is being made in real time: national security .

Many countries in Europe, including France, Greece, Spain, Denmark, Britain, Germany, and many more, are either considering investigating social media platforms over harmful content or considering the imposition of bans on social media access by minors. Why, you may be wondering, is this happening at this point in time ?

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising.

HeartBeam (NASDAQ: BEAT) announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai in New York to accelerate the joint development and validation of next-generation AI-ECG algorithms. The partnership will combine HeartBeam’s patented ECG platform, which captures the heart’s electrical activity from three non-coplanar dimensions, with Mount Sinai’s clinically annotated 12-lead ECG datasets and artificial intelligence expertise to advance AI-driven cardiac monitoring. By leveraging longitudinal, high-fidelity synthesized 12-lead ECG data collected from patients in home settings alongside Mount Sinai’s clinical data resources, the collaboration aims to accelerate the training and validation of AI models designed to support personalized cardiac insights, expand potential clinical indications and enable broader applications in preventive cardiology, chronic disease management and remote patient monitoring.

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.

Renewal Fuels (OTC: RNWF), doing business as American Fusion Inc., was featured in the latest episode of The Stock2Me Podcast released by IBN, highlighting Kepler Fusion Technologies, a wholly owned subsidiary developing the Texatron(TM) aneutronic fusion platform. During the episode, Kepler Fusion CEO Brent Nelson discussed the company’s progress toward deploying a fully operational 100-megawatt fusion reactor, including a 5-megawatt pre-production model currently under development, and outlined its power-as-a-service strategy targeting data centers and industrial customers. Nelson also detailed the company’s economic model and scaling plans, noting potential pricing of approximately 6.25 cents per kilowatt-hour and a long-term goal of delivering about one gigawatt of power by 2028 as the company works to commercialize fusion-based energy solutions.

Tonix Pharmaceuticals (NASDAQ: TNXP) announced two oral presentations on TONMYA(TM), investigated as TNX-102 SL (cyclobenzaprine HCl sublingual tablets), at the 8th International Congress on Controversies in Fibromyalgia held March 9-10, 2026, in Krakow, Poland. Post hoc analyses from the Phase 3 RESILIENT trial and pooled data from the RELIEF and RESILIENT studies highlighted rapid pain relief and a favorable benefit-risk profile for TONMYA in adults with fibromyalgia, including statistically significant reductions in pain and a likelihood of clinical benefit nearly four times greater than discontinuation due to adverse events. TONMYA, the first medication approved for fibromyalgia in more than 15 years, was generally well tolerated, with mild and transient oral cavity reactions reported as the most common adverse events.

Frontieras North America, an energy and environmental technology company commercializing its patented FASForm(TM) Solid Carbon Fractionation process, announced it will host a groundbreaking ceremony on April 2, 2026, for its first commercial facility in Mason County, West Virginia. The estimated $850 million industrial project is expected to create approximately 300 full-time jobs with wages averaging three times the area’s average income, along with about 2,000 construction jobs during the build phase. The ceremony, scheduled for 11:30 a.m. ET, will include remarks from company leadership and federal and state officials, followed by a ceremonial groundbreaking. The company’s FASForm(TM) technology is designed to convert coal and other hydrocarbons into fuels and products such as liquid fuels, hydrogen, fertilizer inputs and industrial carbon through a closed-loop process that captures and repurposes byproducts.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Soligenix (NASDAQ: SNGX) announced that SGX945 (dusquetide) has received Promising Innovative Medicine (“PIM”) designation from the U.K. Medicines and Healthcare Products Regulatory Agency for the treatment of Behçet’s Disease. The designation represents the first step toward potential inclusion in the U.K.’s Early Access to Medicines Scheme, which allows patients with life-threatening or seriously debilitating conditions to access promising therapies earlier. The PIM designation was granted based on Phase 2 clinical data indicating that dusquetide may provide a significant advantage over existing treatments while demonstrating a favorable potential benefit-risk profile for patients with this rare inflammatory disorder.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

This article has been disseminated on behalf of McEwen Inc. and may include paid advertising.

Uranium Energy (NYSE American: UEC) announced that it has filed its Quarterly Report on Form 10-Q for the quarter ended Jan. 31, 2026, highlighting progress across its U.S. in-situ recovery (“ISR”) uranium operations and balance sheet strength. During the quarter, the company completed construction of the Burke Hollow ISR uranium mine, expanded production capacity in Wyoming and South Texas pending final regulatory approvals and advanced feasibility, siting and licensing work for United States Uranium Refining & Conversion Corp. UEC also reported selling uranium at prices more than 25% above the quarterly average while maintaining $818 million in liquid assets and no debt at quarter end, positioning the company to scale production and support development of a vertically integrated U.S. nuclear fuel supply chain.

Lawmakers in Washington State have approved a proposal that would allow patients with terminal illnesses to use medical marijuana in certain healthcare facilities, including hospices, hospitals, and nursing homes. The measure now awaits action from Governor Bob Ferguson.

Recently, LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), a clinical-stage pharmaceutical company, acquired Liora Technologies, a company that is aiming to transform cancer care with innovative compact proton therapy.

Renewal Fuels (OTC: RNWF) (d/b/a American Fusion), an advanced energy platform company focused on the development and commercialization of fusion energy technologies, is working to advance its Texatron(TM) aneutronic fusion system, while simultaneously strengthening governance, engineering leadership and regulatory positioning.

For patients living with rare inflammatory diseases, regulatory milestones can mark the difference between stalled research and meaningful therapeutic progress. A positive opinion from the European Medicines Agency (EMA) not only validates a drug’s scientific rationale but can also unlock development incentives that accelerate its path forward. In that context, Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing treatments for rare diseases and areas of unmet medical need, announced that it has received a positive opinion from the EMA’s Committee for Orphan Medicinal Products for its pipeline product dusquetide in the treatment of Behcet’s disease.

Ongoing digital monitoring could be about to solve one of modern medicine’s most frustrating access problems. Life-extending cancer immunotherapies exist and there are numerous patients who could benefit from such therapies, but a mandatory hospital stay requirement currently makes access to immunotherapy nigh impossible for rural and underserved patients.

Financial services are at a tipping point . Artificial intelligence and modernization are no longer separate trends; they are now deeply connected, reshaping how banks and financial institutions operate, compete, and earn trust.

On Thursday, the prices of gold and silver retreated sharply, putting the precious metals on course to end the week on a low. Several factors could be behind this price movement as the usual suspects, such as a surging USD and rising Treasury yields don’t sufficiently explain this price correction.

Octane announced that the Octane Neuro Tech Forum 2026 will take place March 26-27, 2026, at VEA Newport Beach, A Marriott Resort & Spa in Newport Beach, California, bringing together industry leaders, clinicians, investors and entrepreneurs to advance innovation in neurotechnology. The event, part of Octane’s Innovation Event Series, will feature keynote speaker Dr. Adnan Siddiqui, CEO and CMO of the Jacobs Institute, along with more than 30 expert speakers addressing emerging neurotech technologies, digital health innovation, brain-computer interfaces and the evolving investment landscape. The forum will include innovation panels, investor-focused sessions, company presentations and networking opportunities designed to foster partnerships and accelerate development of next-generation neurotechnology solutions.

This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising.

HeartBeam (NASDAQ: BEAT) stands at a pivotal point in its development as a medical technology company focused on transforming how cardiac arrhythmias are detected, evaluated and monitored. Headquartered in Santa Clara, California, HeartBeam is building a platform designed starting with its FDA-cleared synthesized 12-lead ECG system to bring clinically meaningful ECG data out of traditional healthcare facilities and into more accessible, patient-centered settings.

Wearable Devices (NASDAQ: WLDS), a technology growth company specializing in artificial intelligence-powered touchless sensing wearables, announced it will implement a one-for-three reverse split of its ordinary shares and tradable warrants, effective when trading begins on a split-adjusted basis on March 11, 2026. The action is intended to increase the company’s per-share trading price to regain compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. Following the reverse split, the number of issued and outstanding ordinary shares will be reduced from 10,593,227 to approximately 3,531,076, while publicly held warrants will decrease from 98,589 to about 32,863, with trading to continue under the existing ticker symbols “WLDS” and “WLDSW.” The move was approved by shareholders at a Feb. 19, 2026 special meeting, and the company expects the reverse split to maintain proportional ownership among shareholders, subject to rounding adjustments for fractional shares.

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing advanced cardiac insights, announced that its management team will attend several investor and industry conferences in March 2026. CEO Robert Eno and CFO Timothy Cruickshank will participate in the virtual Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 16-17, including a webcast presentation on March 16, while also meeting with institutional and retail investors. The executives will also attend the 38th Annual ROTH Conference in Dana Point, California, on March 23-24, where Eno will join a panel on technologies advancing healthy aging. In addition, Eno, Founder and President Dr. Branislav Vajdic and Chief Commercial Officer Bryan Humbarger will attend ACC.26, the American College of Cardiology’s annual scientific conference on March 28-30, where the company will showcase its FDA-cleared HeartBeam System and demonstrate a working prototype of its 12-lead ECG extended wear patch to physicians and potential industry partners.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

This article has been disseminated on behalf of G Mining Ventures Corp. and may include paid advertising.

NRx Pharmaceuticals (NASDAQ: NRXP) announced that its subsidiary HOPE Therapeutics has opened a new clinic in Palm Beach, Florida, focused on treating depression and post-traumatic stress disorder through an interventional psychiatry approach that includes ketamine and other neuroplastic drugs, transcranial magnetic stimulation (TMS), hyperbaric oxygen therapy and physician-led psychotherapy. The facility expands HOPE’s growing network of clinics and builds on a nationwide partnership with neurocare AG to bring non-invasive neuroplastic therapies to patients. Peer-reviewed publications cited by the company report an 87% clinical response rate in treatment-resistant depression using short-term treatment protocols, while pilot programs incorporating hyperbaric oxygen therapy have shown a 90% return-to-function rate among patients with depression and PTSD.

Frontieras North America is an energy and environmental technology company focused on redefining how coal and other solid hydrocarbons are utilized within modern energy and industrial systems. Rather than treating coal as a fuel to be burned, the company applies patented processing technology to reform solid hydrocarbons into multiple market-ready energy and industrial products designed for existing global markets.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

A proposal now before the Georgia legislature could significantly change how law enforcement officers handle traffic stops and searches, focusing on the long-debated practice of using the odor of cannabis as grounds for action.

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising.

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, recently acquired Liora Technologies, which is pioneering proton therapy systems for treating tumors in various types of cancers. “Liora is becoming a wholly owned subsidiary of LIXTE, and the acquisition also includes Liora’s proprietary flagship technology, the LiGHT System (Linac for Image Guided Hadron Therapy), which offers many advantages over other technologies that are currently available for treating tumors with proton therapy,” reads an article discussing the move.

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising.

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.

Earth Science Tech (OTC: ETST) was featured in a recent article that discussed its positioning opposite of many capitalization structures in the landscape of over-the-counter (“OTC”) markets, with its management team owning over 47% of the company’s shares. “This high level of insider ownership is significant, as it shows the leadership team strongly believes in the company and has financial outcomes tied closely to the stock’s performance,” reads the publication. “As a result, this greatly reduces the risk that management benefits while investors don’t, as management is financially aligned with outside investors… This high insider ownership also ensures the company is intensely focused on creating shareholder value, as even a tiny swing in the stock price could have massive financial implications for the team… and also points to the company funding operations through cash flow, and not toxic financing.”

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

Artificial intelligence has triggered a global race for computing capacity, but a serious bottleneck is beginning to emerge: electricity . For companies building and operating AI infrastructure, access to reliable power is becoming as critical as access to advanced semiconductors. That shift is creating opportunities for GridAI Technologies (NASDAQ: GRDX), a technology company focused on intelligent energy orchestration.